abstract |
The present disclosure specifically provides compounds of formula (I) that are modulators of the C5a receptor or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions and methods of use, including treatment and non-pharmaceutical use of diseases or disorders associated with pathological activation from C5a. |